Peter J Houghton

Mosse, Y. P., Fox, E., Teachey, D. T., Reid, J. M., Safgren, S. L., Carol, H., Lock, R. B., Houghton, P. J., Smith, M. A., Hall, D., Barkauskas, D. A., Krailo, M., Voss, S. D., Berg, S. L., Blaney, S. M. & Weigel, B. J., Jun 1 2019, In : Clinical Cancer Research. 25, 11, p. 3229-3238 10 p.

Research output: Contribution to journal › Article

Open Access

Leukemia

Aurora Kinase A

Neoplasms

Pharmacokinetics

Pharmacogenetics

Broad spectrum activity of the checkpoint kinase 1 inhibitor prexasertib as a single agent or chemopotentiator across a range of preclinical pediatric tumor models

Lowery, C. D., Dowless, M., Renschler, M., Blosser, W., VanWye, A. B., Stephens, J. R., Iversen, P. W., Lin, A. B., Beckmann, R. P., Krytska, K., Cole, K. A., Maris, J. M., Hawkins, D. S., Rubin, B. P., Kurmasheva, R. T., Houghton, P. J., Gorlick, R., Anders Kolb, E., Kang, M. H., Patrick Reynolds, C. & 4 othersErickson, S. W., Teicher, B. A., Smith, M. A. & Stancato, L. F., Apr 1 2019, In : Clinical Cancer Research. 25, 7, p. 2278-2289 12 p.

Research output: Contribution to journal › Article

Pediatrics

Neoplasms

Combination Drug Therapy

Heterografts

Cell Line

Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children’s Oncology Group (COG) new agents for ewing sarcoma task force [version 1; peer review: 3 approved]

Bailey, K., Cost, C., Davis, I., Glade-Bender, J., Grohar, P., Houghton, P. J., Isakoff, M., Stewart, E., Laack, N., Yustein, J., Reed, D., Janeway, K., Gorlick, R., Lessnick, S., DuBois, S. & Hingorani, P., Jan 1 2019, In : F1000Research. 8, 493.

Research output: Contribution to journal › Review article

Open Access

Peer Review

Ewing's Sarcoma

Oncology

Proxy

Advisory Committees

Evaluation of entinostat alone and in combination with standard-of-care cytotoxic agents against rhabdomyosarcoma xenograft models

Kurmasheva, R. T., Bandyopadhyay, A., Favours, E., Del Pozo, V., Ghilu, S., Phelps, D. A., Erickson, S. W., Peer, C. J., Figg, W. D., Smith, M. A. & Houghton, P. J., Jan 1 2019, In : Pediatric Blood and Cancer. e27820.

Research output: Contribution to journal › Article

Rhabdomyosarcoma

Cytotoxins

Standard of Care

Heterografts

Pharmacokinetics

Preclinical activity of the antibody-drug conjugate denintuzumab mafodotin (SGN-CD19A) against pediatric acute lymphoblastic leukemia xenografts

Jones, L., McCalmont, H., Evans, K., Mayoh, C., Kurmasheva, R. T., Billups, C. A., Houghton, P. J., Smith, M. A. & Lock, R. B., Jan 1 2019, In : Pediatric Blood and Cancer. e27765.

Research output: Contribution to journal › Article

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Heterografts

Gregory Aune, Peter J Houghton & Gail Tomlinson

6/11/18

1 item of media coverage

Press/Media: Press / Media